BCL10 and prostate cancer: Sustained overexpression of BCL-10 may trigger exhaustion programs through chronic NF-κB stimulation, as observed in tumor-infiltrating lymphocytes from human prostate cancer (54), colitis-associated cancer (55)and melanoma tumor (56, 57).